CagriSema is a combination of cagrilintide and semaglutide, which leverages the benefits of both a long-acting amylin analog and a GLP-1 receptor agonist to enhance weight loss, potentially offering a dual mechanism of action that current treatments don't provide
Certificate of Authenticity Access: The company states it provides customers access to view Certificates of Authenticity for their products, allowing verification of testing results rather than relying solely on company claims
No research directly compares the combination to either alone
Serving Information: Serving Size: 1 oral strip Servings per Container: 30 Active Ingredients: BPC-157: 500mcg Thymosin Alpha 1: 50mcg Daily Serving Daily Serving Recommendation: Consume 1 strip daily to receive the full 500mcg of BPC-157 and 50mcg of Thymosin Alpha 1
Life stages including pregnancy, breastfeeding and different age groups
For the vast majority of research applications, BAC water is the only logical choice
